Toward a chronotherapy of neoplasia: tolerance of treatment depends upon host rhythms.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000633:toxicity; D001854:Bone Marrow Cells; D002940:Circadian Rhythm; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D004361:Drug Tolerance; D004386:Duodenum / Q000166:cytology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007942:Leukemia, Experimental / Q000188:drug therapy; D007962:Leukocytes / Q000166:cytology; D008099:Liver / Q000166:cytology; D051379:Mice; D008938:Mitosis; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy*; D010179:Pancreas / Q000166:cytology; D011833:Radiation Injuries, Experimental; D051381:Rats; D012867:Skin / Q000166:cytology
D000970:Antineoplastic Agents; D003561:Cytarabine